RSV Antiviral

Advertisement

cGxPJobs Banner

ArkBio Advances Ziresovir in FDA-Approved Phase II RSV Trial

Shanghai, China, August 14, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that the U.S. Food and Drug Administration...

By cGxPwire Editor
August 15, 2026

Read More

Advertisement

cGxPJobs

Directory